Skip to main content
logo
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
33.26
-0.12 (-0.36%)
At close: Jun 8, 2026, 4:00 PM EDT
33.27
+0.01 (0.03%)
After-hours: Jun 8, 2026, 4:10 PM EDT

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $193.52M in the quarter ending March 31, 2026, with 8.87% growth. This brings the company's revenue in the last twelve months to $796.33M, up 19.88% year-over-year. In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth.

Revenue (ttm)
$796.33M
Revenue Growth
+19.88%
P/S Ratio
1.36
Revenue / Employee
$1,882,577
Employees
423
Market Cap
1.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025780.57M149.12M23.62%
Dec 31, 2024631.45M64.68M11.41%
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Phibro Animal Health1.50B
Evotec SE859.03M
Pacira BioSciences734.86M
Amphastar Pharmaceuticals720.53M
Alvotech562.04M
Esperion Therapeutics418.24M
Xeris Biopharma Holdings314.85M
Harrow268.68M
Revenue Rankings

COLL News

More News